TY  - GEN
AU  - Ock,Chan-Young
AU  - Yoo,Shin-Hye
AU  - Keam,Bhumsuk
AU  - Kim,Miso
AU  - Kim,Tae Min
AU  - Jeon,Yoon Kyung
AU  - Kim,Dong-Wan
AU  - Chung,Doo Hyun
AU  - Heo,Dae Seog
TI  - Clinical factors affecting progression-free survival with crizotinib in ALK-positive non-small cell lung cancer
SN  - 2005-6648
PY  - 2020///0303
KW  - Adolescent
KW  - Adult
KW  - Aged
KW  - Aged, 80 and over
KW  - Anaplastic Lymphoma Kinase
KW  - antagonists & inhibitors
KW  - Antineoplastic Agents
KW  - adverse effects
KW  - Carcinoma, Non-Small-Cell Lung
KW  - drug therapy
KW  - Clinical Decision-Making
KW  - Crizotinib
KW  - Decision Support Techniques
KW  - Disease Progression
KW  - Female
KW  - Humans
KW  - Lung Neoplasms
KW  - Male
KW  - Middle Aged
KW  - Progression-Free Survival
KW  - Protein Kinase Inhibitors
KW  - Reproducibility of Results
KW  - Risk Assessment
KW  - Risk Factors
KW  - Time Factors
KW  - Young Adult
N1  - Publication Type: Journal Article; Validation Study
UR  - https://doi.org/10.3904/kjim.2018.011
ER  -